Literature DB >> 30227390

Fat-to-Lean Mass Ratio Can Predict Cardiac Events and All-Cause Mortality in Patients Undergoing Hemodialysis.

Hyung-Seok Lee1,2, Sung Gyun Kim1,2, Jwa-Kyung Kim1,2, Young Ki Lee3,2, Jung Woo Noh3,2, Jieun Oh4,2, Hyung Jik Kim1,2, Young Rim Song1,2.   

Abstract

BACKGROUND: Although higher body mass index (BMI) is associated with better survival in patients undergoing dialysis, BMI is not an adequate obesity indicator. We hypothesized that the fat-to-lean (F/L) mass ratio could be a suitable marker of nutritional status and evaluated its prognostic impact on long-term outcomes in patients undergoing hemodialysis (HD).
METHODS: In total, 131 patients undergoing HD were recruited and monitored prospectively for up to 5 years. Body composition was analyzed, and other nutritional and inflammatory parameters were measured.
RESULTS: The mean age of the cohort was 60.7 ± 13.6 years, and 65 patients were diabetic. Age, sex, diabetes, comorbidity, and inflammation were associated significantly with the F/L mass ratio. During the follow-up period, 21 patients experienced cardiac events and 22 patients died. Patients with higher F/L mass ratios had significantly higher risks of all-cause death (hazard ratio [HR] 3.61, 95% CI 1.07-12.13; p = 0.038) and cardiac events (HR 3.54, 95% CI 1.05-11.94; p = 0.041) than those with lower F/L mass ratios.
CONCLUSIONS: The F/L mass ratio was a useful surrogate marker of nutritional and inflammatory status, and an independent predictor of cardiac events and all-cause mortality, in patients undergoing HD.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Cardiac events; Fat-to-lean mass ratio; Hemodialysis; Mortality

Mesh:

Year:  2018        PMID: 30227390     DOI: 10.1159/000492939

Source DB:  PubMed          Journal:  Ann Nutr Metab        ISSN: 0250-6807            Impact factor:   3.374


  7 in total

1.  Exploring Muscle Health Deterioration and Its Determinants Among Community-Dwelling Older Adults.

Authors:  Yuan-Ping Chao; Wen-Hui Fang; Wei-Liang Chen; Tao-Chun Peng; Wei-Shiung Yang; Tung-Wei Kao
Journal:  Front Nutr       Date:  2022-04-29

2.  Fat-to-muscle ratio as a predictor of insulin resistance and metabolic syndrome in Korean adults.

Authors:  Young-Gyun Seo; Hong Ji Song; Young Rim Song
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-02-07       Impact factor: 12.910

3.  Mid-arm circumference, body fat, nutritional and inflammatory biomarkers, blood glucose, dialysis adequacy influence all-cause mortality in hemodialysis patients: A prospective cohort study.

Authors:  Tuyen Van Duong; Pei-Yu Wu; Te-Chih Wong; Hsi-Hsien Chen; Tso-Hsiao Chen; Yung-Ho Hsu; Sheng-Jeng Peng; Ko-Lin Kuo; Hsiang-Chung Liu; En-Tzu Lin; Yi-Wei Feng; Shwu-Huey Yang
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

4.  Late stage 3 chronic kidney disease is an independent risk factor for sarcopenia, but not proteinuria.

Authors:  Jung Nam An; Jwa-Kyung Kim; Hyung-Seok Lee; Sung Gyun Kim; Hyung Jik Kim; Young Rim Song
Journal:  Sci Rep       Date:  2021-09-16       Impact factor: 4.379

5.  Fat-to-muscle ratio as a predictor for dyslipidaemia in transitional-age youth.

Authors:  Jia-Xing Zhang; Wen Li; Xiu-Juan Tao; Chen Chen; Qing-An Wang; Wan-Lu Liu; Chan Yang; Kai-Rong Wang; Jiang-Wei Qiu; Yi Zhao; Yu-Hong Zhang
Journal:  Lipids Health Dis       Date:  2022-09-19       Impact factor: 4.315

6.  Serum levels of protein carbonyl, a marker of oxidative stress, are associated with overhydration, sarcopenia and mortality in hemodialysis patients.

Authors:  Young Rim Song; Jwa-Kyung Kim; Hyung-Seok Lee; Sung Gyun Kim; Eun-Kyoung Choi
Journal:  BMC Nephrol       Date:  2020-07-16       Impact factor: 2.388

Review 7.  Three compartment bioimpedance spectroscopy in the nutritional assessment and the outcome of patients with advanced or end stage kidney disease: What have we learned so far?

Authors:  Natascha J H Broers; Bernard Canaud; Marijke J E Dekker; Frank M van der Sande; Stefano Stuard; Peter Wabel; Jeroen P Kooman
Journal:  Hemodial Int       Date:  2020-01-22       Impact factor: 1.812

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.